Medicine guide
NUVAXOVID
As listed in the register: NUVAXOVID, dispersion injectable. Vaccin contre la COVID-19 (recombinant, avec adjuvant)
5 microgrammes · dispersion injectable
- Prescription only
- Active substance
- Protéine Spike (S) Recombinante Du Sars-Cov-2
- Made by
- SANOFI WINTHROP INDUSTRIE
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | SANOFI WINTHROP INDUSTRIE |
|---|---|
| Active substance | Protéine Spike (S) Recombinante Du Sars-Cov-2 |
| Strength | 5 microgrammes |
| Form | dispersion injectable |
| Route | intramusculaire |
| Dispensing (as stated by the register) | liste I |
| Marketed | No — authorised but not currently marketed, according to the register |
| Reinforced monitoring | Yes — under reinforced monitoring, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/21/1618 |
| Name in the register | NUVAXOVID, dispersion injectable. Vaccin contre la COVID-19 (recombinant, avec adjuvant) |
| Packs | 10 flacons multidoses en verre de 5 mL de 10 doses (100 doses) |
| CIS | 69544189 |
| CIP13 | 3400930245774 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).